Results 71 to 80 of about 51,066 (193)

Hyperhomocysteinemia and acute phase proteins in various forms of ischemic heart disease

Терапевтический архив, 2004
Aim. To determine clinical significance of high concentrations of homocystein, C-reactive protein, fibrinogen in various forms of ischemic heart disease. Material and methods.
A D Paramonov, S V Moiseev, V V Fomin, M V Kopeleva, L I Stankevich, A I Martynov, N A Mukhin   +6 more
doaj  

A Pharmaco‐Epidemiological Research Program Leveraging a Nationwide Database of Kidney Transplantation

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 8, August 2026.
ABSTRACT Objectives The pharmaco‐epidemiological research program in kidney transplantation (PERP‐KT) aims to evaluate, for the principal maintenance immunosuppressive drugs (MISDs): the influence of model‐informed precision dosing on graft and patient survival; long‐term exposure—effects relationships; and the benefit‐harm balance of their ...
Pierre Marquet, Antoine Humeau, Sabrina Crépin, Clément Benoist, Sylvain Couderc, Caroline Monchaud, Marc Labriffe, Franck Saint‐Marcoux   +7 more
wiley   +1 more source

Evaluation of Role of C-Reactive Protein Level on Cardiovascular Events During 14 Days after Admission of Patients with Unstable Angina in the Ekbatan Hospital, Hamadan, 2002

پزشکی بالینی ابن سینا, 2007
Introduction & Objective: Unstable angina is in the center of spectrum from chronic stable angina to acute myocardial infarction. Due to high prevalence of unstable angina, it is important to find a factor that predicts prognosis and management modality.
Behshad Naghsh Tabrizi, Farzad Emami
doaj  

Expert considerations to guide the development and delivery of an exercise intervention in people with type 2 diabetes‐related foot ulcer disease

Diabetic Medicine, Volume 43, Issue 8, August 2026.
Abstract Objective Engaging in exercise presents unique challenges for those with type 2 diabetes (T2D) and diabetes‐related foot ulcer disease (DFUD). This brief report describes the development of practical considerations aiming to support exercise in people with T2D and DFUD.
Vicki L. Johnson, Vicky Hall, Rachel Berrington, Julia Burdon, Sally Schreder, Matthew McCarthy, Chris Brough, Patrick J. Highton, Michelle Hadjiconstantinou, Frances L. Game, Lisa J. Keogh, Solomon Tesfaye, Jonathan Valabhji, John R. Petrie, Ketan K. Dhatariya, Tom Yates, Melanie J. Davies, Kamlesh Khunti   +17 more
wiley   +1 more source

Relationship between the level of blood plasma amino acids with daily amount of group ventricular extrasystoles and the duration of pain or painless myocardial ischemia in patients with stable and unstable angina

Доповiдi Нацiональної академiї наук України
It is now known that the human body suffering from coronary heart disease is trying to adapt to new working conditions through biochemical rearrangements, one of which is to increase the involvement of amino acids in car diomyocyte metabolism.
T.V. Bogdan
doaj   +1 more source

Can patients with left main coronary artery disease wait for myocardial revascularization surgery?

Arquivos Brasileiros de Cardiologia, 2003
OBJECTIVE: To assess the occurrence of cardiac events in patients diagnosed with left main coronary artery disease on diagnostic cardiac catheterization and waiting for myocardial revascularization surgery.
Antônio Sérgio Cordeiro da Rocha, Paulo Roberto Dutra da Silva   +1 more
doaj   +1 more source

Survodutide for the Treatment of Obesity Disease in Japanese Participants: Rationale, Design and Baseline Characteristics of the Phase 3 SYNCHRONIZE‐JP Trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 6595-6606, August 2026.
ABSTRACT Aims There is an unmet need for effective pharmacotherapy for obesity disease management in Japan. Survodutide is a novel glucagon receptor/glucagon‐like peptide‐1 receptor (GLP‐1R) dual agonist with the potential to induce greater weight reductions than GLP‐1R mono‐agonists. We report the design and baseline participant characteristics of the
Koutaro Yokote, Toshimasa Yamauchi, Yasushi Fukushima, Yoji Takatsuka, Marie Kato, Shijia Yan, Takayoshi Inoue, Luiza Borowska, Martina Brueckmann, Wataru Ogawa, on behalf of the SYNCHRONIZE‐JP Trial Investigators   +10 more
wiley   +1 more source

Platelets of unstable angina patients as effector cells in terahertz radiation at NO frequency

Кардиоваскулярная терапия и профилактика, 2005
Aim. To investigate the effects of electromagnetic terahertz waves at NO MSIP (molecular specter of radiation and absorption), 240 Hz, on platelet functional activity Р in natural electromagnetic field, as well as in crossed magnetic and electric fields ...
V. F. Kirichuk, E. V. Andronov, A. P. Krenitsky, V. D. Tupikin, A. V. Mayborodin, O. V. Betsky   +5 more
doaj  

The Effects of Combined Antihypertensive and Antidiabetic Therapies on Cardiovascular Outcomes: A Systematic Review and Meta‐Analysis

Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 6874-6887, August 2026.
ABSTRACT Aims Hypertension and diabetes frequently coexist, yet the net clinical impact of intentionally combining antihypertensive (AHTN) and antidiabetic (ADA) therapies on cardiovascular (CV) outcomes is uncertain. Here we quantified the effects of AHTN and ADA co‐therapy on CV and blood pressure (BP)/heart rate (HR) outcomes.
Wan Chin Hsieh, Brandon Michael Henry, István Édes   +2 more
wiley   +1 more source

The changing epidemiology of human type 2 diabetes–associated atherosclerosis: Pathophysiological mechanisms and emerging treatment possibilities

Journal of Internal Medicine, Volume 300, Issue 2, Page 131-152, August 2026.
Abstract Type 2 diabetes (T2D) is a major global health concern strongly associated with atherosclerosis and subsequent macrovascular complications. These complications are the leading cause of death among T2D patients. Despite a decline in cardiovascular events over the last decade, individuals with T2D still have an approximately doubled risk ...
Dania Al‐Sharify, Jiangming Sun, Andreas Edsfeldt   +2 more
wiley   +1 more source